| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102322802-B1 |
| titleOfInvention |
Polymorphic form of RAD1901-2HCL |
| abstract |
Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, have been prepared and characterized. The use of various polymorphic forms of RAD1901-2HCl for the treatment of cancer is also disclosed. |
| priorityDate |
2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |